Terms ending in 2038
Every in-force patent on Codiak Biosciences, Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,195,290 | Preparation of Therapeutic Exosomes Using Membrane Proteins In force · High confidence | Lonza Sales AG | In force | High confidence | |
| US 10,561,740 | Preparation of Therapeutic Exosomes Using Membrane Proteins In force · Low confidence | Lonza Sales AG | In force | Low confidence | |
| US 10,723,782 | Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy In force · High confidence | Lonza Sales AG | In force | High confidence | |
| US 11,679,164 | Preparation of Therapeutic Exosomes Using Membrane Proteins In force · Low confidence | Lonza Sales AG | In force | Low confidence | |
| US 12,030,924 | Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy In force · High confidence | Lonza Sales AG | In force | High confidence | |
| US 12,257,313 | Preparation of Therapeutic Exosomes Using Membrane Proteins In force · Low confidence | Lonza Sales AG | In force | Low confidence | |
| US 12,331,100 | Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy In force · High confidence | Lonza Sales AG | In force | High confidence | |
| US 12,357,571 | Loading of Extracellular Vesicles Through Imparting of Mechanical Shear In force · High confidence | Lonza Sales AG | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Codiak Biosciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.